Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33010107

Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Sci
Publication date
2020 Dec
First author
Fukano R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Fukano R
      type
      Author
    2. name
      Mori T
      type
      Author
    3. name
      Sekimizu M
      type
      Author
    4. name
      Choi I
      type
      Author
    5. name
      Kada A
      type
      Author
    6. name
      Saito AM
      type
      Author
    7. name
      Asada R
      type
      Author
    8. name
      Takeuchi K
      type
      Author
    9. name
      Terauchi T
      type
      Author
    10. name
      Tateishi U
      type
      Author
    11. name
      Horibe K
      type
      Author
    12. name
      Nagai H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Fukano R
      type
      Author
    2. name
      Mori T
      type
      Author
    3. name
      Sekimizu M
      type
      Author
    4. name
      Choi I
      type
      Author
    5. name
      Kada A
      type
      Author
    6. name
      Saito AM
      type
      Author
    7. name
      Asada R
      type
      Author
    8. name
      Takeuchi K
      type
      Author
    9. name
      Terauchi T
      type
      Author
    10. name
      Tateishi U
      type
      Author
    11. name
      Horibe K
      type
      Author
    12. name
      Nagai H
      type
      Author
    bibliography ids
    1. nci-bib-6acd987115c74a2d3f365d94
    book metadata
    content sha256
    668b41d4e8ef3e6b8ab21c23feabff979694f7ecdc3a2815fef482134e8582db
    document type
    citation
    dois
    1. 10.1111/cas.14671
    electronic publication date
    display
    2020 Oct 28
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33010107
    immutable id
    pubmed:33010107@668b41d4e8ef3e6b8ab21c23feabff979694f7ecdc3a2815fef482134e8582db
    journal
    abbreviation
    Cancer Sci
    issn electronic
    1349-7006
    issn print
    1347-9032
    issue
    12
    name
    Cancer science
    nlm unique id
    101168776
    pages
    4540-4547
    volume
    111
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33010107
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      05939730313d618edba664a3a89845555d1a660e6e78783bc5e2135675ad5124
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2020 Dec
      precision
      month
      year
      2020
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33010107/
      title
      Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial.

      Preserved source evidence · Not medical advice